Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma

Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma

Xiaoju Zhou,1,2,* Mengzi Zhang,2,* Bryant Yung,2 Hong Li,2 Chenguang Zhou,2 L James Lee,3,4 Robert J Lee2,41State Key Laboratory of Virology, Ministry of Education Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Wuhan University School of Pharmaceutical Sciences, Wuhan, People&a...

Full description

Bibliographic Details
Main Authors:	Zhou X, Zhang M, Yung B, Li H, Zhou C, Lee LJ, Lee RJ
Format:	Article
Language:	English
Published:	Dove Medical Press 2012-10-01
Series:	International Journal of Nanomedicine
Online Access:	http://www.dovepress.com/lactosylated-liposomes-for-targeted-delivery-of-doxorubicin-to-hepatoc-a11277

Similar Items

Albumin-Albumin/Lactosylated Core-Shell Nanoparticles: Therapy to Treat Hepatocellular Carcinoma for Controlled Delivery of Doxorubicin
by: Nayelli Guadalupe Teran-Saavedra, et al.
Published: (2020-11-01)

Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma
by: Wei MY, et al.
Published: (2015-08-01)

Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles
by: Bian Y, et al.
Published: (2020-02-01)

Lactosylated Albumin Nanoparticles: Potential Drug Nanovehicles with Selective Targeting Toward an In Vitro Model of Hepatocellular Carcinoma
by: Nayelli Guadalupe Teran-Saavedra, et al.
Published: (2019-04-01)

Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma
by: Sandhya Pranatharthiharan, et al.
Published: (2017-01-01)

Doxorubicin and ABT-199 Coencapsulated Nanocarriers for Targeted Delivery and Synergistic Treatment against Hepatocellular Carcinoma
by: Yun Zhou, et al.
Published: (2019-01-01)

Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma
by: Yu Xia, et al.
Published: (2019-01-01)

Thermally-Induced Lactosylation of Whey Proteins: Identification and Synthesis of Lactosylated β-lactoglobulin Epitope
by: Alessandra Gasparini, et al.
Published: (2020-03-01)

Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes
by: Zhang W, et al.
Published: (2015-07-01)

Synthesis of Lactosyl phytosphingosine analogues
by: Wei-Cheng Lu, et al.
Published: (2004)

MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma
by: Yin-Ping Fan, et al.
Published: (2017-06-01)

Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy
by: Wang WY, et al.
Published: (2019-07-01)

Membrane protein-chimeric liposome-mediated delivery of triptolide for targeted hepatocellular carcinoma therapy
by: Yanwen Zheng, et al.
Published: (2021-01-01)

Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4
by: Lian B, et al.
Published: (2021-01-01)

Targeted Cancer Therapy with Liposomal Doxorubicin
by: Yun-Long Tseng, et al.
Published: (1999)

Impact of Focused Ultrasound-Enhanced Targeted Liposomal Doxorubicin Delivery in Mice with Glioma
by: Ming-Che Teng, et al.
Published: (2011)

Retinoic Acid Decorated Albumin-Chitosan Nanoparticles for Targeted Delivery of Doxorubicin Hydrochloride in Hepatocellular Carcinoma
by: Jaleh Varshosaz, et al.
Published: (2013-01-01)

Mannosylated liposomes for targeted gene delivery
by: Kong F, et al.
Published: (2012-02-01)

Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib
by: Duan W, et al.
Published: (2018-07-01)

Mild Hyperthermia Responsive Liposomes for Enhanced In Vitro and In Vivo Anticancer Efficacy of Doxorubicin against Hepatocellular Carcinoma
by: Muhammad Abdur Rahim, et al.
Published: (2021-08-01)

The Roles of Doxorubicin in Hepatocellular Carcinoma
by: Kin Tam
Published: (2013-08-01)

Delivery Of miR-375 And Doxorubicin By Lipid-Coated Hollow Mesoporous Silica Nanoparticles To Overcome Multiple Drug Resistance In Hepatocellular Carcinoma [Corrigendum]
by: Xue H, et al.
Published: (2019-11-01)

Delivery of miR-375 and doxorubicin hydrochloride by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma
by: Xue H, et al.
Published: (2017-07-01)

CHARACTERIZATION OF IMMOBILIZED LIPASE IN ALUMINOSILICATE FOR LACTOSYL PALMITATE SYNTHESIS
by: Anna Roosdiana, et al.
Published: (2010-06-01)

In Vitro Cell Toxicity and Intracellular Uptake of Doxorubicin Exposed as a Solution or Liposomes: Implications for Treatment of Hepatocellular Carcinoma
by: Fredrik Kullenberg, et al.
Published: (2021-07-01)

Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment
by: Liang X, et al.
Published: (2021-03-01)

Targeted delivery of doxorubicin
by: Chitphet, Khanidtha
Published: (2019)

Preclinical verification of the efficacy by targeting peptide-linked liposomal nanoparticles for hepatocellular carcinoma therapy
by: Cheng-Der Wu, et al.
Published: (2019-12-01)

Aptamer–drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity
by: Dou XQ, et al.
Published: (2018-02-01)

Doxorubicin–Cisplatin Conjugated Anticancer Drug forLiposomal Co-Delivery
by: Chia-Yun Hsu, et al.
Published: (2018)

Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma
by: Bang Soo-Mee, et al.
Published: (2006-01-01)

Chondroitin Sulfate-Modified Liposomes for Targeted Co-Delivery of Doxorubicin and Retinoic Acid to Suppress Breast Cancer Lung Metastasis
by: Zhiwei Zhang, et al.
Published: (2021-03-01)

Ratiometric delivery of doxorubicin and berberine by liposome enables superior therapeutic index than DoxilⓇ
by: Ruoshi Zhang, et al.
Published: (2020-05-01)

Cholesterol Derivatives Based Charged Liposomes for Doxorubicin Delivery: Preparation, In Vitro and In Vivo Characterization
by: Yu Nie, Li Ji, Hong Ding, Li Xie, Li Li, Bin He, Yao Wu, Zhongwei Gu
Published: (2012-01-01)

Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy
by: Ling Yu, et al.
Published: (2021-07-01)

A Study of Liposomal Doxorubicin in Combination of Liposomal Vinorelbine for Treating Colon Carcinoma in a Mouse Model
by: Jo-Hsin Tang, et al.
Published: (2014)

Biocompatible Chitosan Nanobubbles for Ultrasound-Mediated Targeted Delivery of Doxorubicin
by: Xiaoying Zhou, et al.
Published: (2019-01-01)

Developing EGFR-expressing cells targeting liposomal doxorubicin (LipoDox)
by: Kai-Mei Hsu, et al.
Published: (2017)

PEGylated Liposomal Doxorubicin Rechallenge following Doxorubicin-induced Pancreatitis
by: Luke Ardolino, et al.
Published: (2020-12-01)

Pharmacokinetics of a liposomal formulation of doxorubicin in rats
by: Zongyu Liu, et al.
Published: (2017-05-01)